Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers.

Janwillem W H Kocks, Hans Wouters, Sinthia Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Evgeni Dvortsin, Marina Garcia Pardo, Asparuh Gardev, Radosław Gawlik, Iris van Geer-Postmus, Iris van der Ham, Marten Harbers, Alberto de la Hoz, Ymke Janse, Marjan Kerkhof, Federico Lavorini, Tiago Maricoto, Jiska Meijer, Boyd Metz, David Price, Miguel Roman-Rodriguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Omar Usmani, Marika T Leving

Journal: NPJ primary care respiratory medicine 2022;32(1):18

PMID: 35618739

Abstract

The study aimed to determine the associations of Peak Inspiratory Flow (PIF), inhalation technique and adherence with health status and exacerbations in participants with COPD using DPI maintenance therapy. This cross-sectional multi-country observational real-world study included COPD participants aged ≥40 years using a DPI for maintenance therapy. PIF was measured three times with the In-Check DIAL G16: (1) typical PIF at resistance of participant's inhaler, (2) maximal PIF at resistance of participant's inhaler, (3) maximal PIF at low resistance. Suboptimal PIF (sPIF) was defined as PIF lower than required for the device. Participants completed questionnaires on health status (Clinical COPD Questionnaire (CCQ)), adherence (Test of Adherence to Inhalers (TAI)) and exacerbations. Inhalation technique was assessed by standardised evaluation of video recordings. Complete data were available from 1434 participants (50.1% female, mean age 69.2 years). GOLD stage was available for 801 participants: GOLD stage I (23.6%), II (54.9%), III (17.4%) and IV (4.1%)). Of all participants, 29% had a sPIF, and 16% were shown able to generate an optimal PIF but failed to do so. sPIF was significantly associated with worse health status (0.226 (95% CI 0.107-0.346), worse units on CCQ; p = 0.001). The errors 'teeth and lips sealed around mouthpiece', 'breathe in', and 'breathe out calmly after inhalation' were related to health status. Adherence was not associated with health status. After correcting for multiple testing, no significant association was found with moderate or severe exacerbations in the last 12 months. To conclude, sPIF is associated with poorer health status. This study demonstrates the importance of PIF assessment in DPI inhalation therapy. Healthcare professionals should consider selecting appropriate inhalers in cases of sPIF.

© 2022. The Author(s).

Address: General Practitioners Research Institute, Groningen, The Netherlands. [email protected].; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, The Netherlands. [email protected].; Observational and Pragmatic Research Institute, Singapore, Singapore. [email protected].; Department of Pulmonology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. [email protected].; General Practitioners Research Institute, Groningen, The Netherlands.; Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.; Sydney Local Health District, Sydney, Australia.; Life and Health Sciences Research Institute (ICVS), PT Government Associate Laboratory, School of Medicine, University of Minho, Braga, Portugal.; Woolcock Institute of Medical Research, University of Sydney, Sydney, Australia.; Radboud University Medical Center, Nijmegen, The Netherlands.; Primary Care Respiratory Research Unit, Instituto De Investigación Sanitaria De Baleares (IdISBa), Palma de Mallorca, Spain.; Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.; Department of Internal Medicine, Allergology, Clinical Immunology, Medical University of Silesia, Katowice, Poland.; Department of Clinical and Experimental Medicine, Careggi University Hospital, Florence, Italy.; Faculty of Health Sciences, University of Beira Interior, Covilha, Portugal.; Observational and Pragmatic Research Institute, Singapore, Singapore.; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.; Department of Social Medicine, Health Planning Unit, Faculty of Medicine, University of Crete, Rethymno, Greece.; Airway Disease, National Heart and Lung Institute (NHLI), Imperial College London and Royal Brompton Hospital, London, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.